combination
Showing 1 - 25 of >10,000
COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)
Not yet recruiting
- COPD
- Ipratropium / Levosalbutamol Fixed Dose Combination
- Ipratropium + Levosalbutamol Free Dose Combination
- (no location specified)
Sep 13, 2023
COPD Trial (Ipratropium / Levosalbutamol Fixed Dose Combination, Ipratropium + Levosalbutamol Free Dose Combination)
Not yet recruiting
- COPD
- Ipratropium / Levosalbutamol Fixed Dose Combination
- Ipratropium + Levosalbutamol Free Dose Combination
- (no location specified)
Jun 5, 2023
Combination Taping in Knee Osteoarthritis Trial in Jeddah (Combination taping)
Recruiting
- Combination Taping in Knee Osteoarthritis
- Combination taping
-
Jeddah, Makkah, Saudi ArabiaBatterjee Medical College
Feb 23, 2023
Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)
Recruiting
- Ovarian Cancer Recurrent
- IN10018
- +2 more
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023
Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination
Not yet recruiting
- Salivary Gland Cancer
- vedicitumomab (Edisil, RC48)
- +3 more
- (no location specified)
Jun 9, 2023
Sensorineural Hearing Loss, Tinnitus Trial (Combination Solution)
Not yet recruiting
- Sensorineural Hearing Loss
- Tinnitus
- Combination Solution
- (no location specified)
Sep 7, 2023
Peripheral T-cell Lymphoma Trial (Linperlisib in combination with CHOP)
Not yet recruiting
- Peripheral T-cell Lymphoma
- Linperlisib in combination with CHOP
- (no location specified)
Jul 10, 2023
Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)
Completed
- Thalassemia, Beta
- Hydroxyurea and Thalidomide
-
Karachi, Sindh, PakistanChildren's Hospital Karachi
Nov 23, 2023
Healthy Volunteer Study Trial (Fixed-Dose Combination (FDC) Tablet)
Not yet recruiting
- Healthy Volunteer Study
- Fixed-Dose Combination (FDC) Tablet
- (no location specified)
Sep 22, 2023
Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,
Not yet recruiting
- Colorectal Cancer
- HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
- HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
- (no location specified)
Jul 13, 2023
Breast Cancer Trial (Utidelone Injection in combination with AC, Docetaxel Injection in combination with AC)
Not yet recruiting
- Breast Cancer
- Utidelone Injection in combination with AC
- Docetaxel Injection in combination with AC
- (no location specified)
Jan 10, 2023
Advanced Solid Tumors Trial (AK127 in combination with AK112)
Not yet recruiting
- Advanced Solid Tumors
- AK127 in combination with AK112
- (no location specified)
Jul 11, 2023
Aqueous Humor Drainage Trial in Mbour (eyeTube)
Active, not recruiting
- Aqueous Humor Drainage
- eyeTube
-
Mbour, SenegalSenghor Centre
Jun 12, 2023
Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)
Not yet recruiting
- Obesity
- Naltrexone-Bupropion (NB) Combination
- Placebo
- (no location specified)
Oct 18, 2023
Helicobacter Pylori Infection Trial (Lacidophilin tablets in combination with vonorazan dual therapy, Placebo in combination
Not yet recruiting
- Helicobacter Pylori Infection
- Lacidophilin tablets in combination with vonorazan dual therapy
- Placebo in combination with vonorazan dual therapy
- (no location specified)
Feb 18, 2023
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Nail Psoriasis Trial in Assiut (Excimer laser, Methotrexate Injection)
Not yet recruiting
- Nail Psoriasis
- Excimer laser
- Methotrexate Injection
-
Assiut, EgyptFaculty of Medicine
Nov 28, 2023
HER2-positive Breast Cancer Trial (Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab))
Not yet recruiting
- HER2-positive Breast Cancer
- Tucatinib (Combination of tucatinib-Oral VP16-trastuzumab)
- (no location specified)
Jul 20, 2023
IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)
Not yet recruiting
- IDH1-mutant Cholangiocarcinoma
- Ivosidenib
- +3 more
- (no location specified)
Jun 29, 2023
NMIBC Trial in Beijing (RC48-ADC in Combination with gemcitabine)
Recruiting
- NMIBC
- RC48-ADC in Combination with gemcitabine
-
Beijing, Beijing, ChinaPeking University First Hosptital
Jul 10, 2023
Lymphedema Arm Trial (BioBridge)
Not yet recruiting
- Lymphedema Arm
- BioBridge
- (no location specified)
Apr 20, 2023
Laparoscopic Cholecystectomy, Postoperative Nausea and Vomiting Trial in Banha, Tanta (normal Saline, Dexamethasone,
Not yet recruiting
- Laparoscopic Cholecystectomy
- Postoperative Nausea and Vomiting
- normal Saline
- +3 more
-
Banhā, Egypt
- +1 more
Aug 10, 2023
FDC, Diabetes, Type 2 Trial in Cheongju-si (DWC202213, DWJ1563, DWP16001)
Recruiting
- FDC
- Diabetes Mellitus, Type 2
- DWC202213
- +2 more
-
Cheongju-si, Seowon-gu, Korea, Republic ofChungbuk National University Hospital
Feb 10, 2023
Gingivitis Trial in Alexandria (Chamomile extract mouthwash, Pomegranate peel extract mouth wash, Combination of 5% chamomile
Not yet recruiting
- Gingivitis
- Chamomile extract mouthwash
- +4 more
-
Alexandria, EgyptFaculty of Pharmacy, Alexandria University
Jul 11, 2023